Tag: Drugs: Misc.
September 2020 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for September 2020. This roundup includes the latest...
2009 to 2019 Saw Increase in Exposure to Phenibut in U.S.
Exposure resulted in moderate effects in 49.6 percent of cases and major effects in 12.6 percent
August 2020 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for August 2020. This roundup includes the latest...
July 2020 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for July 2020. This roundup includes the latest...
April 2020 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for April 2020. This roundup includes the latest...
FDA Issues Emergency Use Authorization for Remdesivir
Remdesivir can be administered intravenously to treat COVID-19 patients with severe disease
Remdesivir May Accelerate Recovery From Severe COVID-19
Early results from NIH study promising, but Lancet study did not show significant clinical benefit
Diabetes Medication Prescribing Increased 2003 to 2016
However, authors say there is little evidence that doctors are tailoring treatment for patients
March 2020 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for March 2020. This roundup includes the latest...
February 2020 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for February 2020. This roundup includes the latest...
